{"id":454,"date":"2014-09-15T00:06:42","date_gmt":"2014-09-15T00:06:42","guid":{"rendered":"http:\/\/stg-blogs.bmj.com\/jnnp\/?p=454"},"modified":"2014-09-15T00:06:42","modified_gmt":"2014-09-15T00:06:42","slug":"interferons-the-safety-continues","status":"publish","type":"post","link":"https:\/\/stg-blogs.bmj.com\/jnnp\/2014\/09\/15\/interferons-the-safety-continues\/","title":{"rendered":"Interferons:  The safety continues!"},"content":{"rendered":"<p>In the new ear of MS drugs, safety has been an important consideration.\u00a0 The risk of cancer in patients treated with IFNs has been raised, although never proven.\u00a0 In this issue of JNNP, a large study from British Columbia categoricaly excludes the association of any cancers with MS.\u00a0 Interestingly, there was a non-signifcant increase in the risk of breast cancer, most likely a chance occurence.<\/p>\n<p>&nbsp;<\/p>\n<p>Must read more at:\u00a0 http:\/\/jnnp.bmj.com\/content\/85\/10\/1096.abstract<\/p>\n<p>&nbsp;<\/p>\n<div id=\"slugline\"><cite> <span id=\"article-slug-jnl-abbr\"> <abbr class=\"slug-jnl-abbrev\" title=\"Journal of Neurology, Neurosurgery &amp; Psychiatry\"> J Neurol Neurosurg Psychiatry<\/abbr> <\/span> <span class=\"slug-pub-date\">2014;<\/span><span class=\"slug-vol\">85<span class=\"cit-sep cit-sep-after-article-vol\">:<\/span><\/span><span class=\"slug-pages\">1096-1102 <\/span> <span class=\"slug-doi\" title=\"10.1136\/jnnp-2013-307238\"> doi:10.1136\/jnnp-2013-307238 <\/span> <\/cite><\/div>\n<ul class=\"subject-headings last-child\">\n<li>Multiple sclerosis<\/li>\n<\/ul>\n<ul class=\"series-titles\">\n<li>Research paper<\/li>\n<\/ul>\n<div class=\"article abstract-view \">\n<h1 id=\"article-title-1\">Assessment of cancer risk with \u03b2-interferon treatment for multiple sclerosis<\/h1>\n<\/div>\n<p><!--TrendMD v2.4.8--><\/p>\n","protected":false},"excerpt":{"rendered":"<p>In the new ear of MS drugs, safety has been an important consideration.\u00a0 The risk of cancer in patients treated with IFNs has been raised, although never proven.\u00a0 In this issue of JNNP, a large study from British Columbia categoricaly excludes the association of any cancers with MS.\u00a0 Interestingly, there was a non-signifcant increase in [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary understrap-read-more-link\" href=\"https:\/\/stg-blogs.bmj.com\/jnnp\/2014\/09\/15\/interferons-the-safety-continues\/\">Read More&#8230;<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-454","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/stg-blogs.bmj.com\/jnnp\/wp-json\/wp\/v2\/posts\/454","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stg-blogs.bmj.com\/jnnp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stg-blogs.bmj.com\/jnnp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stg-blogs.bmj.com\/jnnp\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/stg-blogs.bmj.com\/jnnp\/wp-json\/wp\/v2\/comments?post=454"}],"version-history":[{"count":0,"href":"https:\/\/stg-blogs.bmj.com\/jnnp\/wp-json\/wp\/v2\/posts\/454\/revisions"}],"wp:attachment":[{"href":"https:\/\/stg-blogs.bmj.com\/jnnp\/wp-json\/wp\/v2\/media?parent=454"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stg-blogs.bmj.com\/jnnp\/wp-json\/wp\/v2\/categories?post=454"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stg-blogs.bmj.com\/jnnp\/wp-json\/wp\/v2\/tags?post=454"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}